Skip to content

Clinical trials

Attention Deficit Disorder with Hyperactivity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Country / region: United States Clear all

795 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20019
20027
200317
200424
200535
200629
200735
200834
200937
201035
201123
201230
201323
201448
201540
201642
201734
201837
201930
202022
202126
202231
202330
202432
202531
202631

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed587
Recruiting73
Terminated45
Unknown status32
Withdrawn20
Active, not recruiting18
Not yet recruiting9
Enrolling by invitation9
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital58
Children's Hospital Medical Center, Cincinnati36
Shire33
Otsuka Pharmaceutical Development & Commercialization, Inc.20
Supernus Pharmaceuticals, Inc.19
Duke University18
Eli Lilly and Company18
Florida International University18
National Institute of Mental Health (NIMH)17
New York State Psychiatric Institute16

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity795
Autism Spectrum Disorder25
Spasm24
Oppositional Defiant Disorder23
Autistic Disorder22
Conduct Disorder22
Substance-Related Disorders20
Attention Deficit and Disruptive Behavior Disorders16
Anxiety Disorders15
Bipolar Disorder11

Trials

Showing 1 to 25 of 795. Each trial links to its page on Pharma Observatory.

695 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.